GDF15 and myalgic encephalomeyelitis/chronic fatigue syndrome: The diagnostic ability of GDF-15 to distinguish patients with PMM from patients with CFS, based on ROC curve analysis, showed an area under the curve (AUC) = 0.95 (95% CI 0.88–1.00) (Figure 2a).